Adial Pharmaceuticals

Adial (NASDAQ: ADIL) develops (i) medicinal therapies addiction & related disorders. Lead program in Phase 3 for alcohol use disorder in genetically identified patients (companion diagnostic).

Address

Glen Allen
VA
United States
Loading